This article doesn’t cover it (specifically) so I went digging to see if this might compete with weight loss drugs as well:
Victoza (liraglutide) is also used to treat obesity. While it was originally approved for the treatment of type 2 diabetes, it has also been approved under the brand name Saxenda for chronic weight management in adults with obesity or who are overweight with at least one weight-related condition such as hypertension, type 2 diabetes, or dyslipidemia. Saxenda and Victoza contain the same active ingredient, liraglutide, but they are marketed and dosed differently depending on the indication.
Google said:
As of April 2024, the list price for a 30-day supply of Saxenda (liraglutide) is around $1,350, but the actual cost can range from $1,590 to $1,656 without insurance or discounts.